MOSCOW (Reuters) – The clinical trial of a Russian COVID-19 vaccine being developed by the Siberian Vektor research centre is due to be completed in September, the RIA news agency cited Russia’s healthcare watchdog as saying on Friday.
(Reporting by Andrey Kuzmin; Writing by Tom Balmforth; Editing by David Goodman)
